PubMed
open access
CC BY-NC 4.0
Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.#1086199
- Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above#307311
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age#18719
- Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized#28430
- Covid-19 and influenza vaccine hesitancy insights from France, Italy and Hungary: A mixed-methods study.#9886
Record · ID 409749
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive